AZN peer analysis
AstraZeneca (AZN) against its competitors: price, today's move, 1-year return and market value side by side.
- AZN's peers: ABBV (AbbVie), AMGN (Amgen), BMY (Bristol-Myers Squibb), JNJ (Johnson & Johnson), LLY (Eli Lilly), MRK (Merck), NVO (Novo Nordisk), NVS (Novartis).
AZN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABBV AbbVie | $286.20 | 0.94% | 22.88% | $505.89B |
| AMGN Amgen | $438.50 | -0.07% | 28.07% | $237.19B |
| BMY Bristol-Myers Squibb | $59.00 | 1.13% | 28.85% | $120.60B |
| JNJ Johnson & Johnson | $270.47 | 1.25% | 33.56% | $651.11B |
| LLY Eli Lilly | $1,347.11 | -0.30% | 28.35% | $1.27T |
| MRK Merck | $133.72 | 0.69% | 40.68% | $329.65B |
| NVO Novo Nordisk | $37.82 | -2.70% | -22.82% | $167.31B |
| NVS Novartis | $150.00 | -0.81% | 17.82% | $283.29B |
| PFE Pfizer | $27.44 | -0.36% | 10.29% | $156.40B |
| AZN AstraZeneca | $174.30 | -0.63% | -2.07% | $270.32B |